Castle Biosciences Stock Pattern Recognition Two Crows
| CSTL Stock | USD 26.13 -0.47 -1.77% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of forty-nine. The function did not return any valid pattern recognition events for the selected time horizon. Two Crows is a 3-day pattern that warns about a possible future trend reversal for Castle Biosciences.
Castle Biosciences Technical Analysis Modules
Most technical analysis of Castle Biosciences help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Castle from various momentum indicators to cycle indicators. When you analyze Castle charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Castle Biosciences Inc
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. The company was founded in 2007 and is headquartered in Friendswood, Texas. Castle Biosciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 482 people. Downside history and drawdown behavior provide context for risk expectations in Castle Biosciences. Downside profile remains relatively contained. Castle Biosciences has a market cap of 776.88 M, P/E of 87.86, ROE of -5.21%. 
Raphi Shpitalnik ยท Junior Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Castle Biosciences is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Castle (USA Stocks:CSTL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Castle Biosciences may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Castle Stock is Curated By:
Raphi Shpitalnik ยท Junior Member of Macroaxis Editorial BoardLearn to be your own money manager
Tracking Castle Biosciences inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Castle Biosciences pair trading
Pair trading with Castle Biosciences can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Castle Biosciences Pair Trading
Castle Biosciences Pair Trading Analysis
The information in the correlation table below can inform Castle Biosciences tax-loss harvesting decisions, showing which instruments historically move in lockstep with Castle Biosciences and can serve as viable temporary replacements.
Negative correlation assets provide natural hedges against Castle Biosciences positions. When Castle Biosciences's value declines, a negatively correlated instrument tends to rise, partially offsetting portfolio losses.
Pair evaluation and Correlation analysis for Castle Biosciences provide hedging context. This approach is commonly reviewed within sectors and across broader groups.More Resources for Castle Stock Analysis
A structured review of Castle Biosciences often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Castle Biosciences Stock. Highlighted below are reports that provide context for Castle Biosciences Stock:Castle Biosciences has a market cap of 776.88 M, operating margin of -4.4%, ROE of -5.21%. Trending Equities can help frame allocation decisions. The allocation includes a position in Castle Biosciences inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Explore our How to Trade Castle Stock guide to learn how to trade Castle Biosciences effectively.Analysis related to Castle Biosciences should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Quarterly Earnings Growth -0.52 | Earnings Share -0.83 | Revenue Per Share | Quarterly Revenue Growth 0.008 | Return On Assets |
Investors evaluate Castle Biosciences using market value and book value, each describing different facets of the business. Castle Biosciences' market capitalization is 776.88 M. A P/B ratio of 1.68 indicates the market values Castle Biosciences above its accounting book value. Enterprise value stands at 528.26 M. Intrinsic value is an estimate of what Castle Biosciences' fundamentals imply, and it may differ from market and book figures. Analytical frameworks help compare those viewpoints.
Value and price for Castle Biosciences are related but not identical, and they can diverge across cycles. For Castle Biosciences, key inputs include a P/E ratio of 87.86, a P/B ratio of 1.68, a profit margin of -7.02%, and ROE of -5.21%. By contrast, market price reflects the level where buyers and sellers transact.